title: The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome.
abstract: The central nervous system of persons with Down syndrome presents cytoarchitectural abnormalities that likely result from gene-dosage effects affecting the expression of key developmental genes. To test this hypothesis, we have investigated the transcriptome of the cerebellum of the Ts1Cje mouse model of Down syndrome during postnatal development using microarrays and quantitative PCR (qPCR). Genes present in three copies were consistently overexpressed, with a mean ratio relative to euploid of 1.52 as determined by qPCR. Out of 63 three-copy genes tested, only five, nine and seven genes had ratios >2 or <1.2 at postnatal days 0 (P0), P15 and P30, respectively. This gene-dosage effect was associated with a dysregulation of the expression of some two-copy genes. Out of 8258 genes examined, the Ts1Cje/euploid ratios differed significantly from 1.0 for 406 (80 and 154 with ratios above 1.5 and below 0.7, respectively), 333 (11 above 1.5 and 55 below 0.7) and 246 genes (59 above 1.5 and 69 below 0.7) at P0, P15 and P30, respectively. Among the two-copy genes differentially expressed in the trisomic cerebellum, six homeobox genes, two belonging to the Notch pathway, were severely repressed. Overall, at P0, transcripts involved in cell differentiation and development were over-represented among the dysregulated genes, suggesting that cell differentiation and migration might be more altered than cell proliferation. Finally, global gene profiling revealed that transcription in Ts1Cje mice is more affected by the developmental changes than by the trisomic state, and that there is no apparent detectable delay in the postnatal development of the cerebellum of Ts1Cje mice.
authors.affiliation: Unité Mixte de Recherche 7637, Centre National de la Recherche Scientifique, Ecole Supérieure de Physique et de Chimie Industrielles, 10 rue Vauquelin, 75005 Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Dauphinot
authors.forename: R
authors.initials: R
authors.lastname: Lyle
authors.forename: I
authors.initials: I
authors.lastname: Rivals
authors.forename: M Tran
authors.initials: MT
authors.lastname: Dang
authors.forename: R X
authors.initials: RX
authors.lastname: Moldrich
authors.forename: G
authors.initials: G
authors.lastname: Golfier
authors.forename: L
authors.initials: L
authors.lastname: Ettwiller
authors.forename: K
authors.initials: K
authors.lastname: Toyama
authors.forename: J
authors.initials: J
authors.lastname: Rossier
authors.forename: L
authors.initials: L
authors.lastname: Personnaz
authors.forename: S E
authors.initials: SE
authors.lastname: Antonarakis
authors.forename: C J
authors.initials: CJ
authors.lastname: Epstein
authors.forename: P-M
authors.initials: PM
authors.lastname: Sinet
authors.forename: M-C
authors.initials: MC
authors.lastname: Potier
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D002531:Cerebellum / Q000254:growth & development / Q000378:metabolism*; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000235:genetics* / Q000378:metabolism; D018628:Gene Dosage; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental; D051379:Mice; D008810:Mice, Inbred C57BL; D025341:Principal Component Analysis